Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Uterine Cancer 2016 NCI 5R01CA183953-02 Cerenkov luminescence imaging for image-guided cancer surgery GRIMM, JAN SLOAN-KETTERING INST CAN RESEARCH NY $511,313
Uterine Cancer 2016 NCI 4R01CA172490-04 Characterizing and Targeting CHD4 Deficiency in Endometrial Cancer LIN, SHIAW-YIH UNIVERSITY OF TX MD ANDERSON CAN CTR TX $323,036
Uterine Cancer 2016 NCI 4UM1CA173642-04 Women's Health Initiative Cancer Survivor Cohort ANDERSON, GARNET FRED HUTCHINSON CANCER RESEARCH CENTER WA $2,396,733
Uterine Cancer 2016 NCI 5R01CA183877-02 Pathobiology and Mechanism of Progesterone Resistance in Human Endometrial Cancer MEMARZADEH, SANAZ UNIVERSITY OF CALIFORNIA LOS ANGELES CA $352,275
Uterine Cancer 2016 NIGMS 1R01CA194496-01A1 Molecular Mechanisms and Applications of Novel ER/GPER-selective Ligands PROSSNITZ, ERIC UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $320,000
Uterine Cancer 2016 NCI 5R01CA175486-03 Systematic Functional Characterization of RNA Editing in Endometrial Cancer LIANG, HAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $332,000
Uterine Cancer 2016 NCI 1R01CA193455-01A1 NCOA6, A Novel Tumor Suppressor of Endometrial Cancer XU, JIANMING BAYLOR COLLEGE OF MEDICINE TX $374,023
Uterine Cancer 2016 NCI 7R01CA168755-04 Inflammation and immunity in the crucible of premalignancy ERLEBACHER, ADRIAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $455,336
Uterine Cancer 2016 NCI 4R01CA155513-05 Influence of AKT pathway on progesterone receptor function in endometrial cancer KIM, JI-YONG NORTHWESTERN UNIVERSITY AT CHICAGO IL $320,588
Uterine Cancer 2016 NCI 1R44CA203350-01 Genetic Cytology for Ovarian and Endometrial Cancer Screening KINDE, ISAAC PAPGENE, INC. MD $296,784
Uterine Cancer 2016 NCI 5U10CA180868-03 NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER WOLMARK, NORMAN NRG ONCOLOGY FOUNDATION, INC. PA $12,115,890
Uterine Cancer 2016 NCI 4R01CA099908-14 Targeted Therapy for Endometrial Cancer LESLIE, KIMBERLY UNIVERSITY OF IOWA IA $252,448
Uterine Cancer 2016 NCI 4R01CA175100-04 Revving-Up Exercise for Sustained Weight-Loss by Altering Neurological Reward & D NOCK, NORA CASE WESTERN RESERVE UNIVERSITY OH $535,042
Uterine Cancer 2016 NCI 5U01CA176067-03 Integrated genomic analysis of racial disparities in endometrial cancer SANTIN, ALESSANDRO YALE UNIVERSITY CT $348,353
Uterine Cancer 2016 NCI 5R01CA176502-03 Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer GOLD, LESLIE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $583,157
Uterine Cancer 2016 NCI 1R01CA196975-01A1 First in-human PET imaging studies of NIS reporter [18F]BF4 DEGRADO, TIMOTHY MAYO CLINIC ROCHESTER MN $156,394
Uterine Cancer 2016 NCI 5R03CA188459-02 Mouse Model of Diet-Enduced Endometrial Cancer SLACK-DAVIS, JILL UNIVERSITY OF VIRGINIA VA $79,000
Uterine Cancer 2016 NCI 4P01CA077839-15 7365 PTEN-C0X2-mT0R SIGNALING IN ENDOMETRIAL CANCER DEY, SUDHANSU MAYO CLINIC ARIZONA AZ $237,840
Uterine Cancer 2016 NCI 4P01CA077839-15 7367 ANALYTICAL CORE YANG, PEIYING MAYO CLINIC ARIZONA AZ $99,443
Uterine Cancer 2016 NCI 1R21CA205819-01 Modeling the impact of mutations in ubiquitin ligase genes on transcriptional programs in endometrial cancer LESLIE, CHRISTINA SLOAN-KETTERING INST CAN RESEARCH NY $223,677
Uterine Cancer 2016 NCI 1R01CA196912-01A1 Novel tumorigenic mechanisms of the LKB1 tumor suppressor CASTRILLON, DIEGO UT SOUTHWESTERN MEDICAL CENTER TX $370,194
Uterine Cancer 2016 NCI 4R01CA162139-05 The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and BARAKAT, RICHARD SLOAN-KETTERING INST CAN RESEARCH NY $574,604
Uterine Cancer 2016 NCCIH 1R01AT008824-01A1 Botanical derived progestins and their impact on women's health BURDETTE, JOANNA UNIVERSITY OF ILLINOIS AT CHICAGO IL $359,775
Uterine Cancer 2016 NICHD 5R01HD042311-13 Molecular Analysis of Uterine Receptivity LYDON, JOHN BAYLOR COLLEGE OF MEDICINE TX $325,599
Uterine Cancer 2016 NIGMS 5R01GM112524-04 Regulation of the Class IA PI 3-kinase PIK3CB BACKER, JONATHAN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $404,897
Uterine Cancer 2016 NCI 5R01CA192438-03 Epidemiology of the four most frequent cancers following breast cancer MALONE, KATHLEEN FRED HUTCHINSON CANCER RESEARCH CENTER WA $935,354
Uterine Cancer 2016 NCI 5R01CA184101-03 MTDH regulates Fanconi anemia repair pathway to mediate drug resistance MENG, XIANGBING UNIVERSITY OF IOWA IA $313,622
Uterine Cancer 2016 NCI 1R01CA200864-01A1 Molecular Classification of High Grade Endometrial Cancers: Extending TCGA Findings to a Diverse Population COTE, MICHELE WAYNE STATE UNIVERSITY MI $594,568
Uterine Cancer 2016 NCI 5R01CA172279-03 Novel epigenetic paradigm in endometrial cancer recurrence HUANG, TIM UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $308,364
Uterine Cancer 2016 NCI 5R21CA185811-02 Population-based Cohort of Endometrial Cancer Survivors in Utah HASHIBE, MIA UNIVERSITY OF UTAH UT $162,038
Uterine Cancer 2016 NCI 4F31CA174316-05 Structural mutation analysis of PTEN and its possible genotype-phenotype correlat SMITH, IRIS UNIVERSITY OF HOUSTON TX $29,078
Uterine Cancer 2016 NCI 2P50CA098258-11A1 8325 Administrative Core LU, KAREN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $253,930
Uterine Cancer 2016 NCI 2P50CA098258-11A1 8326 Pathology Core BROADDUS, RUSSELL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $189,314
Uterine Cancer 2016 NCI 2P50CA098258-11A1 8327 Biomarkers Core LOOSE, DAVID UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $45,244
Uterine Cancer 2016 NCI 2P50CA098258-11A1 8328 Biostatistics and Bioinformatics Core YUAN, YING UNIVERSITY OF TX MD ANDERSON CAN CTR TX $189,312
Uterine Cancer 2016 NCI 2P50CA098258-11A1 8329 Developmental Research Program BURKE, THOMAS UNIVERSITY OF TX MD ANDERSON CAN CTR TX $151,451
Uterine Cancer 2016 NCI 2P50CA098258-11A1 8330 Career Enhancement Program BODURKA, DIANE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $151,449
Uterine Cancer 2016 NCI 2P50CA098258-11A1 8331 P1: Novel Targeted Strategies for Prevention and Conservative Management of Complex Atypical Hyperplasia and Grade 1 Endometrioid Endometrial Cancer LU, KAREN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $295,325
Uterine Cancer 2016 NCI 2P50CA098258-11A1 8332 P2: CTNNB1 Mutation and Wnt Pathway Activation Define Clinically Aggressive Endometrioid Endometrial Carcinoma BROADDUS, RUSSELL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $295,325
Uterine Cancer 2016 NCI 2P50CA098258-11A1 8333 P3: EphA2 Targeting in Uterine Carcinoma SOOD, ANIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $295,325
Uterine Cancer 2016 NCI 2P50CA098258-11A1 8334 P4: A Framework for Identification of Novel Targeted Therapy Combinations in Endometrial Cancer MILLS, GORDON UNIVERSITY OF TX MD ANDERSON CAN CTR TX $295,325
Uterine Cancer 2016 NCI 5P30CA091842-15 6318 Solid Tumor Therapeutics (Project-007) EBERLEIN, TIMOTHY WASHINGTON UNIVERSITY MO $60,053
Uterine Cancer 2016 NCI 5U54CA143930-07 6423 PARP inhibition with hormonal modulation as a therapy for PTEN driven endometrial tumors MEMARZADEH, SANAZ UNIVERSITY OF CALIFORNIA LOS ANGELES CA $62,030
Uterine Cancer 2016 NCI 5U54CA143931-07 5570 PARP inhibition with hormonal modulation as a therapy for PTEN driven endometrial tumors MEMARZADEH, SANAZ CHARLES R. DREW UNIVERSITY OF MED & SCI CA $53,813
Uterine Cancer 2016 NICHD 1R21HD086402-01A1 Mechanisms of PGRMC1 Action in Endometrial Proliferation PRU, JAMES WASHINGTON STATE UNIVERSITY WA $190,000
Uterine Cancer 2016 NCI 261200800001E-96-0-35 Genotyping for epidemiology studies HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $6,918,585
Uterine Cancer 2016 NCI 261200800001E-96-0-36 Repository Services for epidemiology studies HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $1,886,169
Uterine Cancer 2016 NCI 3UM1CA173642-04S1 Women's Health Initiative Cancer Survivor Cohort ANDERSON, GARNET FRED HUTCHINSON CANCER RESEARCH CENTER WA $170,764
Uterine Cancer 2016 NCI 1F99CA212222-01 Inflammation and gynecologic cancer: the role of prostaglandins in ovarian cancer BARNARD, MOLLIE HARVARD SCHOOL OF PUBLIC HEALTH MA $32,292
Uterine Cancer 2016 NCI 3UM1CA173642-04S2 Relationships between guideline-concordant treatment and survival following an endometrial cancer diagnosis in the Life and Longevity After Cancer Study ANDERSON, GARNET FRED HUTCHINSON CANCER RESEARCH CENTER WA $116,303
Uterine Cancer 2016 NICHD 1R21HD087589-01A1 Generation of a Model to Study Uterine Gland Function SPENCER, THOMAS UNIVERSITY OF MISSOURI-COLUMBIA MO $230,250
Uterine Cancer 2016 NCI 3R01CA176502-03S1 Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer GOLD, LESLIE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $79,392
Uterine Cancer 2016 NCI 3U10CA180868-03S1 NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER WOLMARK, NORMAN NRG ONCOLOGY FOUNDATION, INC. PA $63,524
Uterine Cancer 2016 NCI 4R44CA203350-02 Genetic Cytology for Ovarian and Endometrial Cancer Screening KINDE, ISAAC PAPGENE, INC. MD $989,879
Uterine Cancer 2016 NCI 3U10CA180868-03S2 NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER WOLMARK, NORMAN NRG ONCOLOGY FOUNDATION, INC. PA $750,000
Uterine Cancer 2016 NCI 1ZIACP010126-21 Hormone-Related Cancers BENSON, GRETCHEN NIH $4,616,752
Uterine Cancer 2016 NCI 1ZIACP010128-21 Therapeutic and Diagnostic Factors as Related to Cancer Risk TRABERT, BRITTON NIH $206,904
Uterine Cancer 2016 NCI 1ZIACP010187-12 Cancer Genetic Markers of Susceptibility HOOVER, ROBERT NIH $169,781
Uterine Cancer 2016 NCI 1ZIABC005177-36 Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA POIRIER, MIRIAM NIH $277,985
Uterine Cancer 2016 NCI 1ZIABC011315-07 Molecular characterization of endometrial cancer ANNUNZIATA, CHRISTINA NIH $59,689
Uterine Cancer 2016 NIEHS 1ZIAES103311-01 Environmental Signaling in Reproduction and Pregnancy DEMAYO, FRANCESCO NIH $2,364,550
Uterine Cancer 2016 NHGRI 1ZIAHG200323-12 Genomic, Epigenetic and Functional Analyses of Vertebrate Regulatory Regions ELNITSKI, LAURA NIH $1,714,348
Uterine Cancer 2016 NHGRI 1ZIAHG200338-10 Genomic Analyses of Endometrial Cancer BELL, DAPHNE NIH $1,079,546
Uterine Cancer 2016 NHGRI 1ZIAHG200379-05 Identification of genetic alterations that underlie endometrial carcinosarcomas BELL, DAPHNE NIH $269,887
Uterine Cancer 2016 NCI 261201300016I-0-26100011-1 IGF::OT::IGF HEIGHT AND WEIGHT DATA TO CALCULATE A VALID MEASURE OF BODY MASS INDEX POP: 09/19/2016 - 09/18/2017 HSIEH, MEI-CHIN LSU HEALTH SCIENCES CENTER LA $47,456
Uterine Cancer 2016 NCI 261201300020I-0-26100011-1 IGF::OT::IGF PROGRAM HEIGHT AND WEIGHT DATA TO CALCULATE A VALID MEASURE OF BODY MASS INDEX. PERIOD OF PERFORMANCE: 09/19/2016 - 09/18/2017 WEST, MICHELE UNIVERSITY OF IOWA IA $22,552
Uterine Cancer 2016 NCI 261201300011I-0-26100008-1 IGF::OT::IGFHEIGHT AND WEIGHT DATA TO CALCULATE A VALID MEASURE OF BODY MASS INDEX PERIOD OF PERFORMANCE: 09/19/2016-09/18/2017 KATO, IKUKO WAYNE STATE UNIVERSITY MI $102,762
Uterine Cancer 2016 NCI 261201300012I-0-26100010-1 IGF::OT::IGF HEIGHT AND WEIGHT DATA TO CALCULATE A VALID MEASURE OF BODY MASS INDEX. PERIOD OF PERFORMANCE 9/19/2016 - 9/18/2017 MUELLER, BETH FRED HUTCHINSON CANCER RESEARCH CENTER WA $127,618


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer